News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
ENRIGHT PATRICK G
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,075 shares
@ $0
Sold 1,241 shares
@ $138.1585, valued at
$171.5k
|
|
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/12/2023 |
4
| ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $7.7, valued at
$154k
|
|
| 02/08/2023 |
4
| ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 1,714,285 shares
@ $7, valued at
$12M
|
|
| 11/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.5, valued at
$20k
|
|
| 05/26/2022 |
4
| ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Granted 9,925 options to buy
@ $16.14, valued at
$160.2k
|
|
| 04/29/2022 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed of 175,000 shares
@ $0
Disposed of 1,964,771 shares
@ $0
Acquired 5,023 shares
@ $0
Acquired 2,152 shares
@ $0
Acquired 7,175 shares
@ $0
Acquired 588 shares
@ $0
Acquired 252 shares
@ $0
Acquired 840 shares
@ $0 |
|
| 04/21/2022 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 1,355,000 shares
@ $3.69, valued at
$5M
|
|
| 04/05/2022 |
4
| ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 333,333 shares
@ $15, valued at
$5M
|
|
| 02/02/2022 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Bought 175,000 shares
@ $27, valued at
$4.7M
|
|
| 01/27/2022 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Exercised (in-or-at-the-money) 1,477,125 options to buy
@ $13.2, valued at
$19.5M
|
|
| 08/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2021 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 2,246 shares
@ $0 |
|
| 07/20/2021 |
4
| Longitude Capital Partners II, LLC (10% Owner) has filed a Form 4 on RAPID MICRO BIOSYSTEMS, INC.|
Txns:
| Converted 3,344,038 shares
@ $0
Bought 150,000 shares
@ $20, valued at
$3M
Converted 8,774,007 options to buy
@ $0
Converted 5,654,529 options to buy
@ $0
Converted 2,291,665 options to buy
@ $0
Converted 2,500,000 options to buy
@ $0.01, valued at
$25k
Converted 500,000 warrants
@ $0.05, valued at
$25k
Converted 645,160 options to buy
@ $0.01, valued at
$6.5k
Converted 129,032 warrants
@ $0.05, valued at
$6.5k
|
|
| 07/14/2021 |
3
| Longitude Capital Partners II, LLC (10% Owner) has filed a Form 3 on RAPID MICRO BIOSYSTEMS, INC. |
| 06/01/2021 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 40,000 options to buy
@ $2.59, valued at
$103.6k
|
|
| 05/18/2021 |
4
| ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Converted 2,187,504 shares
@ $0
Bought 909,090 shares
@ $11, valued at
$10M
Converted 2,187,504 preferred shares
@ $0 |
|
| 05/17/2021 |
4
| ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Granted 9,925 options to buy
@ $11, valued at
$109.2k
|
|
| 05/13/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/11/2021 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Converted 2,985,775 shares
@ $0
Bought 235,000 shares
@ $17, valued at
$4M
Converted 1,308,410 preferred shares
@ $0
Converted 1,271,027 preferred shares
@ $0
Converted 406,338 preferred shares
@ $0 |
|
| 05/06/2021 |
3
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 3 on Talaris Therapeutics, Inc. |
| 04/15/2021 |
4
| Longitude Venture Partners IV, L.P. (10% Owner) has filed a Form 4 on Eargo, Inc.|
Txns:
| Disposed of 1,000,000 shares
@ $0
Acquired 5,012 shares
@ $0 |
|
| 01/05/2021 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 8,149 options to buy
@ $3.46, valued at
$28.2k
|
|
| 11/18/2020 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on 89bio, Inc.|
Txns:
| Disposed of 850,000 shares
@ $0
Acquired 2,973 shares
@ $0
Acquired 2,080 shares
@ $0
Acquired 891 shares
@ $0 |
|
| 11/13/2020 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 3,223 shares
@ $145.8102, valued at
$469.9k
Sold 5,083 shares
@ $147.0032, valued at
$747.2k
Sold 1,623 shares
@ $147.6122, valued at
$239.6k
|
|
| 11/04/2020 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Exercised 9,929 options to buy
@ $0 |
|
| 10/22/2020 |
4
| Longitude Venture Partners IV, L.P. (10% Owner) has filed a Form 4 on Eargo, Inc.|
Txns:
| Converted 3,685,358 shares
@ $0
Bought 233,333 shares
@ $18, valued at
$4.2M
Converted 3,685,358 preferred shares
@ $0 |
|
| 10/15/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2020 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 8,379 options to buy
@ $3.38, valued at
$28.3k
|
|
| 09/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/01/2020 |
4
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Molecular Templates, Inc.|
Txns:
| Sold 2,447 shares
@ $10.7461, valued at
$26.3k
Sold 1,049 shares
@ $10.7461, valued at
$11.3k
|
|
|
|
|